Scientists from the Institute of Cancer Research (ICR), London, UK, have developed an algorithm that can predict whether individuals with inflammatory bowel disease (IBD) will develop bowel cancer ...

Hormone replacement therapy taken at age 50 for up to 5 years only modestly increases the risk of breast cancer, even for women with a strong family history of the disease, according to a new risk ...

It usually develops beneath the skin. While an armpit lump can be a symptom of breast cancer, it is not usually the first sign of breast cancer. Instead, the most common symptom of breast cancer is a ...

Bishal Gyawali, MD, PhD, and Sharon Batt, PhD, explore why overall survival continues to be the most patient-centric marker of clinical benefit.

Scientists from the Institute of Cancer Research (ICR) have found a new method for predicting bowel cancer risk in inflammatory ... The team, which worked with doctors at St Mark’s Hospital, is now ...

Breast Cancer Now – which launched a petition to try to get the decision reversed – celebrated what it described as a "landmark victory" but said it now needs "urgent confirmation" as to when ...

28, 2025 — The test can differentiate between various grades of cancer, helping men avoid unnecessary ... Routine Brain MRI Screening in Asymptomatic Late Stage Breast Cancer Patients Jan.

Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu. Sales & Marketing Sponsored ...

Following a broad FDA approval for the adjuvant treatment of HR-positive, HER2-negative early breast cancer in September ... “The biggest focus for us right now is maximizing the opportunity ...